This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
2 Feb 2024

BOTULINUM NEUROTOXINS TYPE A AND B

SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o., would like to kindly invite you to negotiate rights acquisition to the documentation of development of the method for the production and purification of botulinum neurotoxins type A and B.
The project was carried out within Operational Programme Innovative Economy 2007-2013, Action 1.4 “Support for special projects” based on co-financing agreement  POIG.01.04.00-14-008/13. In attachment you can find detailed description of this project.

SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o., would like to kindly invite you to negotiate rights acquisition to the documentation of development of the method for the production and purification of botulinum neurotoxins type A and B.
The project was carried out within Operational Programme Innovative Economy 2007-2013, Action 1.4 “Support for special projects” based on co-financing agreement  POIG.01.04.00-14-008/13. In attachment you can find detailed description of this project.

Mentioned Companies
SciencePharma
View company profile